Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
Founded in 1967, the non-profit AAMI is a unique alliance of over 6,000individuals and 375 organizations from around the world united by the commongoal of increasing the understanding and beneficial use of medicalinstrumentation, as well as the primary resource for the industry, professions,and government for national and international standards. The AAMI standardsprogram consists of over 100 technical committees and working groups thatproduce Standards, Recommended Practices, and Technical Information Reportsfor medical devices. Standards and Recommended Practices represent a nationalconsensus and many have been approved by the American National StandardsInstitute (ANSI) as American National Standards as well as InternationalStandardization Organization (ISO) standards.
Advertisement
Having served as a member of AAMI Sterilization Standards Committee,former co-chair of the AAMI Microbiological Methods Working Group, and expertmember to the ISO TC 198 Micro Methods working group, Ms. Bryans will workregularly with more important responsibilities in her new role of directingand supervising all AAMI technical committee activities relating to thenational standards program.
''I am very honored to be part of the national standards program, and willdo my best to make a worthwhile contribution during my term. As the globalmedical device industry is rapidly growing and related technologies andproducts are converging, it is very important to have a set of standards thathelp regulate the research, development and commercialization of innovativemedical devices,'' said Ms. Bryans.
With over 25 years of experience in medical device industry andinternationally recognized for her work in microbiology and sterilization andprocess validation, Ms. Bryans is responsible for all operations of WuXiAppTec's Atlanta facility. She received her B.S. from University of Georgia,and M(ASCP), microbiology technologist certification by the American Societyfor Clinical Pathology, from Medical College of Georgia. She also completedher M.B.A. course work at Georgia State University.
''We are very proud of Trabue for her expertise and professional status,''commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech.''We are delighted to have such an exceptional individual whose leadership hasmade tremendous impact on not only national standards but also the medicaldevice testing business of WuXi AppTec. We would like to extend our warmcongratulations to Trabue and great support for her new role in AAMI.''
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medicaldevice R&D outsourcing company, with operations in China and the United States.As a research-driven and customer-focused company, WuXi PharmaTech providespharmaceutical, biotechnology and medical device companies a broad andintegrated portfolio of laboratory and manufacturing services throughout thedrug and medical device R&D process. WuXi PharmaTech's services are designedto assist its global partners in shortening the cycle and lowering the cost ofdrug and medical device R&D. For more information, please visit:http://www.wuxipharmatech.com .
SOURCE WuXi PharmaTech (Cayman) Inc.
